|
|
|
Volumn 17, Issue 4, 2005, Pages 6-7
|
|
FDA approves Aptivus (tipranavir).
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROTEINASE INHIBITOR;
PYRIDINE DERIVATIVE;
PYRONE DERIVATIVE;
TIPRANAVIR;
ARTICLE;
DRUG ADMINISTRATION;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG CONTRAINDICATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LEGAL ASPECT;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
UNITED STATES;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
DRUG ADMINISTRATION SCHEDULE;
DRUG APPROVAL;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
PYRIDINES;
PYRONES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33644838799
PISSN: 15518396
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
